Literature DB >> 17699980

Exchange transfusion as an alternative therapy for recurrent severe Guillain-Barre syndrome.

Arun K Baranwal1, Veena R Parmar.   

Abstract

Recurrent Guillain-Barre Syndrome is a rare condition. IVIg and plasmapheresis are costly therapies and may not be affordable. We report a 6-yr-old boy in whom two severe episodes of Guillain-Barre Syndrome were successfully treated by exchange transfusion. Possible explanation for its effectiveness is discussed with respect to available literature.

Entities:  

Mesh：

Year:  2007        PMID： 17699980     DOI： 10.1007/s12098-007-0122-y

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


  10 in total

1.  The efficiency of blood substitution.

Authors:  H WALLERSTEIN; S S BRODIE
Journal:  Am J Clin Pathol       Date:  1948-11       Impact factor: 2.493

Review 2.  Assessment of current diagnostic criteria for Guillain-Barré syndrome.

Authors:  A K Asbury; D R Cornblath
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

3.  Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group.

Authors: 
Journal:  Lancet       Date:  1997-01-25       Impact factor: 79.321

4.  [A study on red blood cell immune function in patients with Guillain-Barré syndrome and multiple sclerosis].

Authors:  X Qi; K Zhu; J Liu
Journal:  Zhonghua Nei Ke Za Zhi       Date:  1996-08

Review 5.  Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies.

Authors:  F G van der Meché; P A van Doorn
Journal:  Ann Neurol       Date:  1995-05       Impact factor: 10.422

6.  Natural history and treatment effects in Guillain-Barré syndrome: a multicentre study.

Authors:  R Korinthenberg; J S Mönting
Journal:  Arch Dis Child       Date:  1996-04       Impact factor: 3.791

7.  Exchange transfusion: a low-cost alternative for severe childhood Guillain-Barré syndrome.

Authors:  Arun K Baranwal; Ravi N M Ravi; Rupa Singh
Journal:  J Child Neurol       Date:  2006-11       Impact factor: 1.987

8.  Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes.

Authors:  W Emlen; V Carl; G Burdick
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

9.  Recurrent Guillain-Barré syndrome. Clinical and laboratory features.

Authors:  F Grand'Maison; T E Feasby; A F Hahn; W J Koopman
Journal:  Brain       Date:  1992-08       Impact factor: 13.501

10.  Recurrent Guillain Barre' syndrome.

Authors:  A Das; J Kalita; U K Misra
Journal:  Electromyogr Clin Neurophysiol       Date:  2004-03
  10 in total
  1 in total

1.  Clinical and pharmacological aspects of inflammatory demyelinating diseases in childhood: an update.

Authors:  Alberto Spalice; Pasquale Parisi; Laura Papetti; Francesco Nicita; Fabiana Ursitti; Francesca Del Balzo; Enrico Properzi; Alberto Verrotti; Martino Ruggieri; Paola Iannetti
Journal:  Curr Neuropharmacol       Date:  2010-06       Impact factor: 7.363
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.